Invention Grant
- Patent Title: Suture line administration technique using botulinum toxins
-
Application No.: US15822573Application Date: 2017-11-27
-
Publication No.: US10220079B2Publication Date: 2019-03-05
- Inventor: Andrew M. Blumenfeld
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte C. Phan
- Main IPC: A61K38/48
- IPC: A61K38/48
Abstract:
The present invention utilizes patient-specific landmarks in order to treat headache pain. In one aspect, the present invention relates to the administration of Clostridial toxins, such as a botulinum neurotoxin, to a patient suffering from a headache pain, where the location of administration of the botulinum toxin is based upon at least one suture line of the patient's skull.
Public/Granted literature
- US20180078622A1 Suture Line Administration Technique Using Botulinum Toxins Public/Granted day:2018-03-22
Information query
IPC分类:
